Still high in themselvesThey covieniently left out the part about their focus on driving shareholder value.
The management of this company has for many years promised to provide shareholder value based on their expertise, knowledge and experience. Not so much.
From the useless BOD (James Rae) to the various leadership groups, McRae and Berendt, you should be held accountable for bad decisions and missed opportunities. Instead, you have looked after yourselves. Disgraceful.
"Telesta is a Montreal-based biotechnology company focused on the licensing/acquisition and development of transformational therapeutics for the treatment of serious human diseases such as cancer, immune diseases and targeted rare diseases. We are agile, pragmatic, efficient, and driven by a passion for breakthrough science, drug development and making a difference in the lives of patients and their families. Through our strong convictions, work ethics, and collaboration-driven approach, we are leveraging our deep expertise and skillsets to bring transformational medicines to patients and their physicians.
Read more at https://www.stockhouse.com/news/press-releases/2016/10/25/telesta-therapeutics-inc-shareholders-approve-plan-of-arrangement-with-prometic#GZDGZ4wfi1Dof8tG.99"